Our current results were in agreement with those of a preliminary experiment performed with KB tumor-bearing mice and [177Lu]cm09, the first DOTA-folate conjugate developed in our group, which was outfitted with an albumin-binding entity (see the Supporting Information of [23]). The gene discussed is ALB; the disease is neoplasm.